FDA Panel Questions Safety of Antidepressants During Pregnancy
TL;DR Summary
The article criticizes the FDA's recent panel discussion on antidepressants during pregnancy, highlighting the spread of misinformation and fringe opinions that contradict established scientific consensus, which states that SSRIs are generally safe for pregnant women. It also discusses the broader political context under RFK Jr.'s leadership, emphasizing the influence of anti-medical and individualistic health movements that challenge mainstream psychiatric treatments.
- Millions of Americans Need These Drugs. RFK Jr.’s Minions Have Them in Their Crosshairs. Slate Magazine
- FDA Panel Casts Doubt on Safety of SSRI Use in Pregnancy Medscape
- An unusual FDA panel on antidepressant use during pregnancy elevated skeptics of the drugs statnews.com
- FDA panel on the use of antidepressants during pregnancy is alarming experts Los Angeles Times
- F.D.A. Panel Debates ‘Black Box’ Warning for Antidepressants in Pregnancy The New York Times
Reading Insights
Total Reads
1
Unique Readers
17
Time Saved
12 min
vs 13 min read
Condensed
98%
2,426 → 60 words
Want the full story? Read the original article
Read on Slate Magazine